Research will target specific regions of DNA strands to understand role of genetic variants
lupus
OMRF to lead nationwide partnership studying autoimmune and immune-mediated diseases
The NIH has selected OMRF to lead a $58.5 million public-private partnership aimed at developing more effective treatments for autoimmune diseases.
New England Journal of Medicine publishes lupus drug trial paper authored by OMRF expert
Clinical trial results illustrate incremental advances in lupus research.
OMRF’s lupus cohort marks 20 years
Tens of thousands of patient samples have contributed to worldwide research.
Life Changer: Oklahoma’s lupus cohort marks 20 years
Oklahoma’s lupus cohort marks 20 years.
Eureka Moments
The new millennium began with a bang at OMRF, as Dr. Jordan Tang, above, and his research team identified and cloned the enzyme believed to cause Alzheimer’s disease. Soon after, the OMRF scientists designed an inhibitor that stopped the enzyme in its tracks. The discoveries led to the development of an experimental drug acquired by […]
